[SYRE] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Mar-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 2.13%
YoY- 24.61%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 1,042 0 688 198 168 174 625 40.47%
PBT -63,180 -40,104 -217,074 -18,458 -18,784 -18,443 -22,314 99.76%
Tax -5,746 3 7 -36 38 -209 9 -
NP -63,180 -40,107 -217,081 -18,422 -18,822 -18,234 -22,323 99.70%
Tax Rate - - - - - - - -
Total Cost 64,222 40,107 217,769 18,620 18,990 18,408 22,948 98.21%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -6,063.34 0.00 -31,552.47 -9,304.04 -11,203.57 -10,479.31 -3,571.68 42.16%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -11.29 -9.34 -56.79 -4.89 -7.20 -4.84 -6.79 40.22%
EPS Diluted -11.29 -9.34 -56.79 -4.89 -7.20 -4.84 -6.79 40.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.